Credo Biomedical will be introducing the CREDO CUBE, its revolutionary Point-Of-Care Molecular Diagnostic Solution.
Online PR News – 12-September-2018 – Singapore – Credo Biomedical Pte. Ltd., a groundbreaking molecular diagnostic company, announced today they will attend the 43rd World Small Animal Veterinary Association Congress 2018 that will take place in at the Marina Bay Sands Expo and Convention Centre in Singapore September 25th through 28th.
Credo Biomedical will be introducing the CREDO CUBE, its revolutionary point-of-care molecular diagnostic solution, for the first time to WSAVA's global veterinary community. Using a proprietary Real Time PCR technology, the CREDO CUBE is an affordable, user friendly and reliable solution that provides diagnostic results in only 15 minutes from a variety of sample types (feces, blood, oral fluid, etc.).
"Today, doctors, medical and veterinary, face the delicate challenge of diagnosis everyday" said Stephen Kao, CEO of Credo Biomedical Pte. Ltd. "The diagnostic companies owe it to the doctors and patients to provide better tools and we are very excited to introduce our revolutionary molecular diagnostic platform to WSAVA's community in Singapore."
Credo Biomedical will be located at the booth #34B, where it will be meeting with individual veterinarians, veterinary associations, and potential business partners.
About Credo Biomedical Pte. Ltd.
Credo Biomedical develops, and manufactures innovative, cost-effective, and rapid Molecular Diagnostic solutions at the Point-of-Care (POC) in the areas of Animal Health, Human Health, and Human Wellness. By providing the right information, at the right time, and to the right people, we can improve the lives of billions of people and animals around the world.
About WSAVA World Congress
WSAVA World Congress is the flagship annual congress of the World Small Animal Veterinary Association, the leading association representing companion animal veterinarians worldwide. Its members include 105 veterinary associations and more than 200,000 individual veterinarians. One of its core activities is the development of WSAVA Global Guidelines in key areas of veterinary practice.